Fujian Cosunter Pharmaceutical Co., Ltd. (SHE:300436)

China flag China · Delayed Price · Currency is CNY
118.89
+12.03 (11.26%)
Apr 29, 2026, 12:44 PM CST
299.09%
Market Cap 17.02B
Revenue (ttm) 430.98M
Net Income (ttm) -197.25M
Shares Out 159.27M
EPS (ttm) -1.24
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 10,664,865
Average Volume 11,796,008
Open 117.75
Previous Close 106.86
Day's Range 110.67 - 121.99
52-Week Range 28.03 - 188.93
Beta 1.24
RSI 54.63
Earnings Date Apr 29, 2026

About SHE:300436

Fujian Cosunter Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It offers drugs for anti-HBV, liver diseases, hepatobiliary disease drugs, metabolism and digestive system, respiratory, cardiovascular, men’s health, and other fields. Fujian Cosunter Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Fuzhou, China. [Read more]

Sector Healthcare
Founded 2001
Employees 760
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300436
Full Company Profile

Financial Performance

In 2025, SHE:300436's revenue was 416.37 million, a decrease of -5.68% compared to the previous year's 441.46 million. Losses were -217.85 million, 39.4% more than in 2024.

Financial Statements

News

There is no news available yet.